Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer
The Uromigos - Ein Podcast von The Uromigos
Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session.
